Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02972047 · ClinicalTrials.gov registry record · NA

Understanding the Pathophysiology and Effects of Diaphragmatic Breathing in Upright Gastroesophageal Reflux

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT02972047: Completed NA study, sponsored by Mayo Clinic.

NCT02972047 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02972047, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

This study aims to understand why patients have predominantly upright gastroesophageal reflux disease by comparing such patients to healthy persons AND whether a behavioral intervention (diaphragmatic breathing) will impact this disease

Primary Outcome

The investigators will compare the total esophageal acid exposure time in minutes during the first 24 hour ambulatory pH study with the second 24 period during which patients are either randomized to biofeedback versus sham

Interventions

  • BEHAVIORAL Diaphragmatic Breathing
  • BEHAVIORAL Sham Comparator

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2017-04-06
Est. Completion 2020-08-30
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT02972047 record still lists

NCT02972047 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which Diaphragmatic Breathing is the first listed.

NCT02972047 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02972047 about?

NCT02972047 is a clinical study titled "Understanding the Pathophysiology and Effects of Diaphragmatic Breathing in Upright Gastroesophageal Reflux". This study aims to understand why patients have predominantly upright gastroesophageal reflux disease by comparing such patients to healthy persons AND whether a behavioral intervention (diaphragmatic breathing) will impact this disease

What is the current status of trial NCT02972047?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2017-04-06. Estimated completion is 2020-08-30.

What interventions are being tested in trial NCT02972047?

The interventions under investigation include: Diaphragmatic Breathing (BEHAVIORAL), Sham Comparator (BEHAVIORAL).

Who is sponsoring clinical trial NCT02972047?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02972047's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02972047, the US trial registry maintained by the National Library of Medicine. NCT02972047 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.